Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy
NCT ID: NCT07041710
Last Updated: 2025-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
104 participants
INTERVENTIONAL
2022-08-16
2027-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this research is therefore to propose a solution to alleviate these taste and smell disorders. Based on the same principle as rehabilitation proposed for anosmia (loss of smell) related to COVID-19, we hypothesize that olfactory rehabilitation (using the sense of smell) through the odorous properties of essential oils could be effective for chemotherapy-related taste and smell alterations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer
NCT04716153
Effects of Aromatherapy on Patients Undergoing Chemotherapy for Breast Cancer
NCT06338527
Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy
NCT02445378
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
NCT07126301
Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment
NCT03858855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
no taste and smell rehabilitation
taste and smell disorders questionnaire
Answer to the home-made questionnaire at inclusion and at 6 months
experimental with day hospital
During the day hospital, patients will be made aware of the various taste and smell disorders by the medical and paramedical team (doctor, dietician-nutritionist, speech therapist, therapeutic education nurse)
experimental in day hospital
multidisciplinary day hospital
taste and smell disorders questionnaire
Answer to the home-made questionnaire at inclusion and at 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
experimental in day hospital
multidisciplinary day hospital
taste and smell disorders questionnaire
Answer to the home-made questionnaire at inclusion and at 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with taste and/or smell disorders
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Médipôle Lyon-Villeurbanne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Médipôle Hôpital Mututaliste
Villeurbanne, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGORA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.